Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Vaccine
|
December 1, 1988
Recombinant fowlpox virus inducing protective immunity in non-avian species
J Taylor, R Weinberg, B Languet, et al.
Comparative Immunology, Microbiology and Infectious Diseases
|
January 1, 1985
Freeze-dried vaccine against Rinderpest: stability and activity study
B Languet, P Precausta, M Mackowiak, et al.
Developments in Biological Standardization
|
January 1, 1996
Stability of recombinant vaccinia-rabies vaccine in veterinary use
P P Pastoret, B Brochier, B Languet, et al.
Vaccine
|
March 1, 1991
Efficacy studies on a canarypox-rabies recombinant virus
J Taylor, C Trimarchi, R Weinberg, et al.
Developments in Biological Standardization
|
January 1, 1994
Applications of canarypox (ALVAC) vectors in human and veterinary vaccination
J Taylor, J Tartaglia, M Rivière, et al.
Vaccine
|
April 1, 1995
Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species
J Taylor, B Meignier, J Tartaglia, et al.
Annales De Recherches Veterinaires. Annals of Veterinary Research
|
January 1, 1989
[Safety and efficacy of an antirabies vaccine consisting of recombinant vaccinia-rabies virus administered orally to the fox, dog and cat]
J Blancou, M Artois, B Brochier, et al.
Journal of Virology
|
October 1, 1989
Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals
P X Guo, S Goebel, S Davis, et al.
The Journal of General Virology
|
January 1, 1990
Primary multiplication site of the vaccinia-rabies glycoprotein recombinant virus administered to foxes by the oral route
I Thomas, B Brochier, B Languet, et al.
Journal of Virology
|
May 1, 1990
Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity
P X Guo, S Goebel, M E Perkus, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Vaccine
|
December 1, 1988
Recombinant fowlpox virus inducing protective immunity in non-avian species
J Taylor, R Weinberg, B Languet, et al.
Comparative Immunology, Microbiology and Infectious Diseases
|
January 1, 1985
Freeze-dried vaccine against Rinderpest: stability and activity study
B Languet, P Precausta, M Mackowiak, et al.
Developments in Biological Standardization
|
January 1, 1996
Stability of recombinant vaccinia-rabies vaccine in veterinary use
P P Pastoret, B Brochier, B Languet, et al.
Vaccine
|
March 1, 1991
Efficacy studies on a canarypox-rabies recombinant virus
J Taylor, C Trimarchi, R Weinberg, et al.
Developments in Biological Standardization
|
January 1, 1994
Applications of canarypox (ALVAC) vectors in human and veterinary vaccination
J Taylor, J Tartaglia, M Rivière, et al.
Vaccine
|
April 1, 1995
Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species
J Taylor, B Meignier, J Tartaglia, et al.
Annales De Recherches Veterinaires. Annals of Veterinary Research
|
January 1, 1989
[Safety and efficacy of an antirabies vaccine consisting of recombinant vaccinia-rabies virus administered orally to the fox, dog and cat]
J Blancou, M Artois, B Brochier, et al.
Journal of Virology
|
October 1, 1989
Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals
P X Guo, S Goebel, S Davis, et al.
The Journal of General Virology
|
January 1, 1990
Primary multiplication site of the vaccinia-rabies glycoprotein recombinant virus administered to foxes by the oral route
I Thomas, B Brochier, B Languet, et al.
Journal of Virology
|
May 1, 1990
Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity
P X Guo, S Goebel, M E Perkus, et al.
Page
of 2